Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Inhibition of the activity of dipeptidyl-peptidase IV as a treatment for type 2 diabetes. / Holst, J.J.; Deacon, C.F.

    In: Diabetes, No. 47, 1998, p. 1663-1670.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    On the treatment of diabetes mellitus with glucagon-like peptide-1. / Holst, J.J.; Deacon, C.F.; Toft-Nielsen, M.; Bjerre-Knudsen, L.

    In: Annals of the New York Academy of Sciences, No. 865, 1998, p. 336-343.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Regulatory Peptides of the Gut. / Holst, J.J.

    Small Bowel Disorders. Kluwer Academic Publishers, 1998.

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  4. Published

    Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus. / Jensen, P.B.; Blume, N.; Mikkelsen, J.D.; Larsen, P.J.; Jensen, H.I.; Holst, J.J.; Madsen, O.D.

    In: J. Clin. Invest., No. 101, 1998, p. 503-510.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Distal small bowel hormones: Correlation with fasting antroduodenal motility and gastric emptying. / Naslund, E.; Gryback, P.; Backman, L.; Jacobsson, H.; Holst, J.J.; Theodorsson, E.; Hellstrom, P.M.

    In: Dig. Dis. Sci., No. 43, 1998, p. 945-952.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. / Naslund, E.; Backman, L.; Holst, J.J.; Theodorsson, E.; Hellstrom, P.M.

    In: Obes. Surg., No. 8, 1998, p. 253-260.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients. / Nauck, M A; Weber, I; Bach, I; Richter, S; Orskov, C; Holst, J J; Schmiegel, W.

    In: Diabetic Medicine Online, Vol. 15, No. 11, 11.1998, p. 937-45.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Normalization of sting glycemia by intravenous GLP-1 (7-36amide) or (7-37) in Type 2 diabetic patients. / Nauck, M.A.; Weber, I.; Bach, I.; Richter, S.H.; Ørskov, C.; Holst, J.J.; Schmiegel, W.

    In: Diabetic Medicine, No. 15, 1998, p. 937-945.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure. / Nauck, M.A.; Sauerwald, A.; Ritzel, R.; Holst, J.J.; Schmiegel, W.

    In: Diabetes Care, No. 21, 1998, p. 1925-1931.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion. / Porksen, N.; Grøfte, T.; Nyholm, Birgit; Holst, J.J.; Pincus, S.M.; Veldhuis, J.D.; Schmitz, O.; Butler, P.C.

    In: Diabetes, No. 47, 1998, p. 45-49.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207